Compare TJX Companies Inc (TJX) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TJX Companies Inc vs State Street SPDR S&P Biotech ETF — how do they compare? TJX Companies Inc trades at $155 (market cap $172.00B), while State Street SPDR S&P Biotech ETF trades at $154.42. The key difference: TJX Companies Inc pays a 1.23% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, TJX Companies Inc nearer its low. Which is the better fit depends on your goals.
| TJX | XBI | |
|---|---|---|
Market Cap | $172.00B | — |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $168.41 | $164.28 |
52-Week Low | $124.53 | $85.16 |
Enterprise Value | $180.60B | — |
Dividend Yield | 1.23% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TJX Companies Inc
TJX is a leading off-price retailer of apparel, home fashions, and other merchandise. It sells a variety of branded goods, opportunistically buying inventory from a network of over 21,000 vendors worldwide. TJX targets undercutting conventional retailers' regular prices by 20%-60%, capitalizing on a flexible merchandising network, relatively low-frills stores, and a treasure-hunt shopping experience to drive margins and inventory turnover. TJX derived 79% of fiscal 2022 revenue from the United States, with 11% from Europe (mostly the United Kingdom and Germany), 9% from Canada, and the remainder from Australia. The company operated 4,689 stores at the end of fiscal 2022 under the T.J. Maxx, T.K. Maxx, Marshalls, HomeGoods, Winners, Homesense, Winners, and Sierra banners.
Read more on TJX →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
